Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience-Reference-Cited by-同舟云学术

Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience

Published:2020-08-25 Issue:1 Volume:14 Page:62-74
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Godfrey Alan¹,Vandendriessche Benjamin²³,Bakker Jessie P.⁴,Fitzer‐Attas Cheryl⁵,Gujar Ninad⁶,Hobbs Matthew⁷,Liu Qi⁸,Northcott Carrie A.⁹,Parks Virginia¹⁰,Wood William A.¹¹,Zipunnikov Vadim¹²,Wagner John A.¹³,Izmailova Elena S.¹⁴

Affiliation:

1. Department of Computer and Information Sciences Northumbria University Newcastle‐upon‐Tyne UK

2. Byteflies Antwerp Belgium

3. Department of Electrical Computer, and Systems Engineering Case Western Reserve University Cleveland Ohio USA

4. Philips Monroeville Pennsylvania USA

5. ClinMed LLC Dayton New Jersey USA

6. Curis Advisors Cambridge Massachusetts USA

7. Cambridge Cognition Boston Massachusetts USA

8. Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research, US Food and Drug Administration Silver Spring Maryland USA

9. Early Clinical Development Pfizer Inc. Cambridge Massachusetts USA

10. Takeda Pharmaceuticals International Co. Cambridge Massachusetts USA

11. Lineberger Comprehensive Cancer Center University of North Carolina North Carolina USA

12. Department of Biostatistics Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

13. Foresite Capital Boston Massachusetts USA

14. Koneksa Health Inc. New York New York USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12865

Reference98 articles.

1. Effect of homologous bone marrow injections in x‐irradiated rabbits;Porter K.A.;Br. J. Exp. Pathol.,1957

2. Sex Chromatin as a Biologic Cell Marker*

3. Biomarkers and surrogate endpoints

4. US Food and Drug Administration.About biomarkers and qualification. Accessed May 11 2020.

5. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. More Than One Enzyme: Exploring Alternative FMN-Dependent L-Lactate Oxidases for Biosensor Development;ACS Omega;2024-06-26

2. The value of single biomarkers in the diagnosis of silicosis: A meta-analysis;iScience;2024-06

3. The Analytical Validity of Stride Detection and Gait Parameters Reconstruction Using the Ankle-Mounted Inertial Measurement Unit Syde®;Sensors;2024-04-10

4. Ethical Considerations and Legal Frameworks for Biometric Surveillance Systems: The Intersection of AI, Soft Biometrics, and Human Surveillance;Lecture Notes in Networks and Systems;2024

5. Untargeted Metabolomics Analysis of Gingival Tissue in Patients with Severe Periodontitis;Journal of Proteome Research;2023-11-29